mortality/aging
• one third of mice die at birth or within 2 days
• however, remaining mice survive beyond 6 months
|
• one third of mice die at birth or within 2 days
• however, remaining mice survive beyond 6 months
|
muscle
• sarcolemma are less uniform, discontinuous, and lacking a plasma membrane compared to in wild-type mice
|
• at 5 weeks
|
• at 5 weeks
|
• at 5 weeks
|
• at 5 weeks
|
• at 10 weeks
|
• in all skeletal muscles at 5 weeks, including tibialis anterior, quadriceps, gastronemius, intercostals, biceps, and diaphragm
• however, the heart is unaffected
|
• as early as 2 weeks of age
|
nervous system
• in the cerebral cortex and cerebellum
|
• 5 of 6 mice exhibit brains that are smoother than in wild-type mice
• mice exhibit interhemispheric fissure unlike wild-type mice
|
• folia are distorted and partially fused unlike in wild-type mice
|
hydrocephaly
(
J:164448
)
• in 4 of 6 mice
|
• some mice exhibit duplication of a portion of the dentate gyrus and improper folding unlike in wild-type mice
• however, 3 of 6 mice exhibit normal hippocampal architecture
|
• the boundary between molecular layers I (MLI) and MLII is obscured unlike in wild-type mice
|
• cellular components are disorganized near the retina unlike in wild-type mice
|
vision/eye
• cellular components are disorganized near the retina unlike in wild-type mice
|
• affected eyes have a haze-like appearance
|
• the size of eyes varies
|
• disrupted by ectopic cells outside of the membrane
|
• disrupted by ectopic cells outside of the membrane
|
homeostasis/metabolism
N |
• mice exhibit normal blood urea nitrogen, alkaline phosphatase, and cholesterol levels
|
• 10 times
|
craniofacial
• outward bulging of the parietal bone
|
• in more than 50% of mice
|
growth/size/body
• throughout adulthood
|
behavior/neurological
skeleton
• outward bulging of the parietal bone
|
• in more than 50% of mice
|
cellular
• in the cerebral cortex and cerebellum
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
autosomal recessive limb-girdle muscular dystrophy type 2I | DOID:0110299 |
OMIM:607155 |
J:164448 | |
muscular dystrophy-dystroglycanopathy type B1 | DOID:0050588 |
OMIM:613155 |
J:164448 | |
muscular dystrophy-dystroglycanopathy type B5 | DOID:0110635 |
OMIM:606612 |
J:164448 |